-
2023-507052-69-00
4
2023-03-29
Multifocal Motor Neuropathy
-
2022-500637-80-00
5
2023-03-28
gastrointestinal stromal tumor
-
2024-513949-37-00
4
2023-03-16
previously untreated aggressive B-cell lymphoma
-
2023-505211-21-00
4
2023-03-10
Previously untreated locally advanced or metastatic non-small cell lun
-
2023-506924-94-00
5
2023-02-28
Cardiovascular disease
-
2024-514173-22-00
5
2023-02-28
Cystic Fibrosis
-
2024-514840-97-00
3
2023-02-15
glioma WHO grade IV (C71.1-9 according to ICD-10 classification)
-
2024-513610-34-00
4
2023-02-13
HER2-positive, localized esophagogastric adenocarcinoma
-
2022-501901-10-00
6
2023-02-06
Chronic Hepatitis D Infection
-
2024-517132-22-00
5
2023-01-26
active ulcerative colitis
-
2022-501744-15-00
5
2023-01-23
Obesity, Overweight
-
2024-511852-42-00
5
2023-01-19
Spinal Muscular Atrophy
-
2023-510061-10-00
3
2023-01-09
Clear cell renal cell carcinoma (ccRCC, first-, second- and third-line
-
2023-505057-40-00
4
2022-12-02
Lung Cancer, Non-Small Cell
-
2023-509825-38-00
5
2022-12-01
Metastatic Non–Small Cell Lung Cancer
-
2023-504741-32-00
4
2022-11-30
Moderately to Severely Active Crohn's Disease
-
2024-510947-71-00
5
2022-11-21
Chronic Myeloid Leukemia
-
2024-515637-14-00
5
2022-11-08
Cystic Fibrosis
-
2023-505628-67-00
5
2022-10-28
Relapsed and Refractory Follicular Lymphoma
-
2023-506929-11-00
5
2022-10-17
Overweight and obesity
-
2024-513638-39-00
1
2022-10-17
Surgically treated high grade glioma after concomitant radiochemothera
-
2023-508265-33-00
5
2022-10-13
Vasomotor symptoms caused by adjuvant endocrine therapy in women with,
-
2024-512368-79-00
4
2022-10-10
Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC)
-
2023-506871-88-00
3
2022-10-07
Relapsed/Refractory Multiple Myeloma